Evading Thermodynamic Constraints of Cyclodextrin-Drug Formulations
Drug Development and Delivery has published on excipients with the title: SPECIAL FEATURE – Excipients: Far From Inactive summarizing the
Category: Drug delivery
Cyclodextrins in Antiviral Therapeutics and Vaccines
The review of Braga et al. describes the various roles of cyclodextrins (CDs) in vaccines againstviruses and in antiviral therapeutics
FDA granted accelerated approval to umbralisib / HPBCD tablet
The Food and Drug Administration granted accelerated approval to umbralisib (Ukoniq, TG Therapeutics), a kinase inhibitor including PI3K-delta and casein
Reduced mortality rate and shorter time for clinical improvement upon Remdesivir treatment
This retrospective comparative effectiveness research study was conducted from March 4 to August 29, 2020, in a 5-hospital health system
Regorafenib@mannose-γ-cyclodextrin channel-type nanoparticles for colorectal cancer therapy
The malignancy of colorectal cancer is connected with inflammation and tumor-associated macrophages (TAMs), but effective therapeutics for colorectal cancer are
Meet the Experts: Applications of Cyclodextrins in the Pharma Industries
A webinar organized by CycloLab will be held on April 15-16, 2021. Participation at the event is provided free of charge
The story of cyclodextrin metal–organic frameworks and their applications from Nobel-prize laureate, F. Stoddart
Cyclodextrin-based metal–organic frameworks (CD-MOFs), derived from γ-cyclodextrin (γ-CD) and alkali metal cations, constitute a class of porous, renewable, and edible
Review on cyclodextrin-based functional systems for biomedical applications
In this review Xu et al. (2021) highlight the characteristics and advantages of CDs as a starting point to design
CPhI Japan
CPhI Japan will be held on01-30 April online and 14 – 16 April 2021 live in Tokyo, Big Sight complex.
Multicharge beta-cyclodextrin supramolecular assembly for ATP capture and drug release
Water-soluble seven hexylimidazolium modified amphiphilic cyclodextrin (AMCD) selectively combined with ATP to form a stable 1 : 1 inclusion complex